Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer
Author:
Affiliation:
1. Department of Pharmacy, Qingdao Jiaozhou Central Hospital, Qingdao, 266300 Shandong, China
2. Pharmacy Department of Qingdao Chest Hospital, Qingdao, 266043 Shandong, China
Abstract
Publisher
Hindawi Limited
Subject
Biomedical Engineering,Bioengineering,Medicine (miscellaneous),Biotechnology
Link
http://downloads.hindawi.com/journals/abb/2022/2756459.pdf
Reference30 articles.
1. Integrative bioinformatics analysis of KPNA2 in six major human cancers;C. B. Xu;Open Medicine,2021
2. Liver transplantation for secondary liver tumours: the difficult balance between survival and recurrence;P. D. Line;Journal of Hepatology,2020
3. Progress and prospects of biomarkers in primary liver cancer;Y. X. Gao;International Journal of Oncology,2020
4. Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma;J. C. Mejia;Surgical Clinics of North America,2020
5. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007;J. L. Petrick;International Journal of Cancer,2016
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent Progress and Challenges Regarding Magnetite-Based Nanoparticles for Targeted Drug Delivery;Applied Sciences;2024-01-29
2. Retracted: Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer;Applied Bionics and Biomechanics;2023-11-01
3. Surface-Modified Biobased Polymeric Nanoparticles for Dual Delivery of Doxorubicin and Gefitinib in Glioma Cell Lines;ACS Omega;2023-07-26
4. Dual pH-/Thermoresponsive Shell-Cross-Linked Magnetic Mesoporous Nanospheres for Doxorubicin Delivery and In Vitro/In Vivo Cancer Treatment;ACS Applied Nano Materials;2023-05-12
5. Magnetic nanoparticles: multifunctional tool for cancer therapy;Expert Opinion on Drug Delivery;2023-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3